Attenuvax Side Effects
Generic name: measles virus vaccine
Medically reviewed by Drugs.com. Last updated on Oct 29, 2023.
Note: This document provides detailed information about Attenuvax Side Effects associated with measles virus vaccine. Some dosage forms listed on this page may not apply specifically to the brand name Attenuvax.
Applies to measles virus vaccine: subcutaneous powder for injection.
Important warnings
This medicine can cause some serious health issues
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with measles is much more dangerous to your health than receiving the vaccine to protect against these diseases. Like any medicine, this vaccine can cause side effects, but the risk of serious side effects is extremely low.
Get emergency medical help if you have any of these signs of an allergic reaction while taking measles virus vaccine (the active ingredient contained in Attenuvax) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:
-
high fever;
-
easy bruising or bleeding, unusual weakness;
-
severe blistering, peeling, and red skin rash;
-
seizure (convulsions);
-
weakness, numbness or tingly feeling in your feet and spreading upward;
-
problems with hearing or vision;
-
problems with eye movement, speech, swallowing, or bladder and bowel functions;
-
severe lower back pain; or
-
slow heart rate, trouble breathing, feeling like you might pass out.
Less serious side effects include:
-
redness, burning, stinging, swelling, blistering, or hives where the shot was given;
-
headache, dizziness;
-
feeling irritable;
-
fussiness, excessive crying;
-
low fever, cough, runny nose;
-
joint or muscle pain; or
-
nausea, vomiting, diarrhea.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For healthcare professionals
Applies to measles virus vaccine: subcutaneous powder for injection.
Local
Local side effects have included injection site burning/stinging, wheal and flare, erythema, swelling, and vesiculation.[Ref]
Hypersensitivity
Hypersensitivity reactions have included anaphylaxis, anaphylactoid reactions, angioneurotic edema (including peripheral or facial edema), and bronchial spasm.[Ref]
Cardiovascular
Cardiovascular side effects have included vasculitis.[Ref]
Dermatologic
Dermatologic side effects have included Stevens-Johnson Syndrome, erythema multiforme, urticaria, and rash.[Ref]
Gastrointestinal
Gastrointestinal side effects have included diarrhea.[Ref]
Hematologic
Hematologic side effects have included thrombocytopenia, purpura, regional lymphadenopathy, and leukocytosis.[Ref]
Musculoskeletal
Musculoskeletal side effects have included arthralgia and/or arthritis (usually transient and rarely chronic), polyneuritis, myalgia, paresthesia, and rarely chronic arthritis; these symptoms may also occur with natural rubella.[Ref]
Nervous system
Nervous system side effects have included measles inclusion body encephalitis (MIBE), encephalopathy, subacute sclerosing panencephalitis (SSPE), Guillain-Barré Syndrome (GBS), febrile convulsions, afebrile convulsions or seizures, ataxia, and ocular palsies.[Ref]
Significant central nervous system reactions such as encephalitis and encephalopathy have been very rarely temporally associated with measles vaccine (occurring within 30 days after vaccination); however, causality has not been determined in any case. A certain number of encephalitis cases unrelated to vaccines is expected to occur in a large childhood population; however, there is the possibility that some of these cases may have been caused by measles vaccine. The risk of measles vaccine-associated serious neurological disorders is much smaller than the risk for encephalitis and encephalopathy due to natural measles.
Subacute sclerosing panencephalitis (SSPE) has been very rarely reported in children after measles vaccination. Some of these cases may have been due to unrecognized measles during the first year of life or possibly due to the measles vaccination. The results of a retrospective case-controlled study by the U.S. Centers for Disease Control and Prevention suggest that measles vaccine has had the overall effect of protecting against SSPE by preventing measles with its greater risk of SSPE.[Ref]
Ocular
Ocular side effects have included retinitis, optic neuritis, papillitis, retrobulbar neuritis, and conjunctivitis.[Ref]
Other
Otic side effects have included nerve deafness and otitis media.[Ref]
Respiratory
Respiratory side effects have included pneumonitis, cough, and rhinitis.[Ref]
Other
Other side effects have included panniculitis, atypical measles, fever, syncope, headache, dizziness, malaise, and irritability. Fatalities have been reported with the polyvalent measles/mumps/rubella vaccine; however, causality has not been determined.
Health care providers should report any allergic or unusual adverse reactions to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 (USA) and the manufacturer.[Ref]
A postmarketing surveillance study of measles/mumps/rubella vaccine in Finland during 1982 to 1993 with 1.5 million pediatric and adult vaccinees reported no deaths or permanent sequelae.[Ref]
References
1. (2022) "Product Information. Attenuvax (measles virus vaccine)." Merck & Co., Inc
More about Attenuvax (measles virus vaccine)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Patient resources
Professional resources
Related treatment guides
Further information
Attenuvax side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.